Patent Assignment
Reel/Frame 047676/0235
Assignment of Assignor's Interest
Recorded: 2018-12-05
Pages: 16
Assignors
EUSTACE, BRENDA
Executed: 2018-12-05
ROSSERT, JEROME
Executed: 2018-12-04
KAUFFMAN, ROBERT
Executed: 2018-12-03
Assignee
VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE, BOSTON, MASSACHUSETTS, 02210
Covered Properties
(5)
Pharmaceutical Compositions for Treating Hemoglobinopathies
Application:
62/594,689 →
Crispr-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells
Application:
62/664,023 →
Crispr-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Related Methods for Treating Beta-Thalassemia
Application:
62/671,770 →
Crispr CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells
Application:
62/734,431 →
Crispr-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Related Methods for Treating Beta-Thalassemia
Application:
62/734,543 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2017
From: LUNDBERG, ANTE SVEN; HO, TONY
To: CRISPR THERAPEUTICS AG
Reel/Frame 044419/0231 →
Assignment of Assignor's Interest
Dec 6, 2018
From: MORAWA, EWELINA; CHAKRABORTY, TIRTHA; LUNDBERG, ANTE SVEN; HO, TONY
To: CRISPR THERAPEUTICS AG
Reel/Frame 047689/0516 →
Assignment of Assignor's Interest
Aug 30, 2019
From: CRISPR THERAPEUTICS AG
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 050219/0163 →